Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "on-site management"
Home
VOYXACT Preserves Kidney Function for Two Years in Phase 3 IgA Nephropathy Trial
Otsuka Pharmaceutical’s VOYXACT (active ingredient: sibeprenlimab) demonstrated long-term kidney protection by maintaining kidney function over a...
08/12/2026, 23:23 ET
South Korea to Deploy AI Across Public Health Centers and Ambulances to Close Care Gaps
Artificial intelligence tools that assist in interpreting X-ray images and drafting clinical notes will soon be deployed to public health centers in...
08/09/2026, 11:04 ET
Why Bones Break Before Osteoporosis Sets In: The Hidden Risk Behind Normal Scans
"I slipped and broke my wrist." "I fell, broke my hip, and even had to get surgery." Most people chalk these injuries...
08/06/2026, 00:00 ET
No Need to Travel to Seoul: How South Gyeongsang Valve Patients Access Local TAVI Treatment
For older adults, heart valve disease can be particularly difficult to detect. Symptoms often develop gradually,...
07/30/2026, 20:45 ET
"1 Million Won a Month Covers Everything"? The Hidden Cost Trap in Long-Term Senior Care
"If you pay in the 1 million won-a-month range, we’ll take care of everything." It is a familiar sales pitch at many...
07/27/2026, 08:06 ET
Placebo Outperforms TG-C: Data Errors and Stock Volatility Cloud Kolon TissueGene’s Phase 3 Trial
Kolon TissueGene’s knee osteoarthritis cell and gene therapy, TG-C, has failed to achieve statistical significance on...
07/27/2026, 08:06 ET
"I Called a Nursing Home. They Said: 'Wait a Year and a Half.'"
When caring for aging parents at home becomes overwhelming, families face a daunting choice between long-term care...
07/26/2026, 08:04 ET
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem
South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for...
07/12/2026, 01:39 ET
Nowhere to Go: Room Amputation of 89-Year-Old Highlights Severe Gaps in Medical Referral System
Calls are growing to address structural blind spots in South Korea's medical referral system for severely ill, elderly...
07/02/2026, 04:25 ET
From AI Medicine to K-Beauty: Medi Expo Korea 2026 Set for Record-Breaking 350-Company Showcase
MEDI EXPO KOREA 2026, a premier summer showcase of South Korea’s healthcare industry and shifting global medical...
06/23/2026, 02:33 ET
Previous
1
2
3
4
Next